伊立替康和替莫唑胺联合达沙替尼和西罗莫司对比伊立替康和替莫唑胺治疗复发或难治性神经母细胞瘤患者的临床研究

Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma(RIST-rNB-2011):A multicentre,open-label,randomised,controlled,phase 2 trial